Skip to main content
Equibles

Vestcor Inc

Position in EXEL — Exelixis, Inc.

CIK 1536925 FREDERICTON, A3
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$7,220,207
+$1,298,600 QoQ
Shares Held
132,700
-3.9% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#146
of 757 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Vestcor Inc holds $65,738,287 across 33 Biotechnology names. EXEL ranks #3 (11.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 27,242 $13,531,918
2 INCY
Incyte Corp
 114,821 $13,016,108
3 EXEL
Exelixis, Inc.
This page 		132,700 $7,220,207
4 APGE
Apogee Therapeutics, Inc.
 50,000 $6,636,500
5 TECH
BIO-TECHNE Corp
 90,000 $6,358,500
6 JAZZ
Jazz Pharmaceuticals plc
 10,959 $2,640,790
7 AUPH
Aurinia Pharmaceuticals Inc.
 119,319 $2,024,843
8 ALNY
Alnylam Pharmaceuticals, Inc.
 6,060 $1,824,241

All Filings in EXEL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,220,207 132,700
2026-03-31 $5,921,607 138,065
2025-12-31 $8,209,227 187,297
2025-09-30 $8,499,333 205,795
2025-06-30 $8,254,685 187,266
2025-03-31 $5,446,327 147,517
2024-12-31 $1,841,689 55,306
2024-09-30 $1,551,524 59,789
2024-06-30 $1,327,235 59,067
2024-03-31 $1,401,659 59,067
2023-12-31 $1,420,495 59,212
2023-09-30 $1,268,086 58,036
2023-06-30 $673,703 35,254
2023-03-31 $684,280 35,254
2022-12-31 $565,474 35,254
2022-09-30 $664,675 42,390
2022-06-30 $733,988 35,254
2022-03-31 $273,536 12,066
2021-12-31 $151,797 8,304
2021-09-30 $195,333 9,240
2021-06-30 $168,352 9,240
2021-03-31 $208,731 9,240
2020-12-31 $185,446 9,240
2020-09-30 $225,918 9,240
2020-06-30 $219,357 9,240